CRISPR-Cas Eliminates Blue-Ear Pig Disease by Targeting CD163 Gene

A team of bio-scientists affiliated with a host of institutions across the U.S. has developed a gene editing technique to produce newborn pigs immune to porcine reproductive and respiratory syndrome, also known as blue-ear pig disease.